Schedule 13G ownership disclosure

SYNERGY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 871639308

Event date: 2017-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-17-000813
Form type
SC 13G/A
Filer
PAULSON & CO. INC.
CIK
CIK 1035674
Filed
Dec 12, 2017
Reporting period
Nov 30, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub